At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
pressure support ventilation versus neurally adjusted ventilatory assistdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pressure Support Ventilation (PSV) Versus Neurally Adjusted Ventilatory Assist (NAVA) in Difficult to Wean Pediatric ARDS Patients: a Physiologic Crossover Study
Fondazione Policlinico Universitario Agostino Gemelli IRCCS·observational·Posted Apr 24, 2020·Updated Oct 6, 2021
In Brief
An observational study evaluating pressure support ventilation versus neurally adjusted ventilatory assist for Distress Respiratory Syndrome and Weaning Failure. Completed, enrolled 12 participants.
Detailed Summary
This study assessed the effects of NAVA versus Pressure Support Ventilation (PSV) on patient-ventilator interaction in pediatric patients with difficult weaning from mechanical ventilation after moderate Pediatric Acute Respiratory Distress Syndrome (PARDS).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDistress Respiratory Syndrome, Weaning Failure
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
Primary CompletionJan 2014
Study CompletionJul 2014
First PostedApr 2020
TodayJul 2026
First PostedApr 24, 2020
Enrollment StartJan 1, 2011
Primary CompletionJan 31, 2014
Study CompletionJul 30, 2014
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 6.2 years ago
Interventions
pressure support ventilation versus neurally adjusted ventilatory assistdevice
All patients underwent three mechanical ventilation modes, lasting 1 hour each: pressure support mode, neurally adjusted ventilatory assist and again pressure support ventilation